HWKN

Hawkins, Inc. (HWKN) - 10-K Summary

Business Context and Reporting Period

Company: Hawkins, Inc.
Filing Type: Form 10-K (Annual Report)
Fiscal Year Ended: April 3, 2005 (53-week year)
Business Overview: Hawkins, Inc. formulates, blends, and distributes bulk and specialty chemicals through three segments: Water Treatment, Industrial, and Pharmaceutical. The company operates primarily in the Upper Midwest United States.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 7.7% to $115.3 million, driven by growth in all three segments. The Industrial segment grew 8.1% due to higher caustic soda prices, while the Pharmaceutical segment grew 14.1% on increased volumes.
• Profitability: Net income rose 40.7% to $8.1 million compared to the prior year. This improvement was significantly aided by the absence of a $3.0 million litigation settlement expense recorded in Fiscal 2004.
• Margins: Gross margin percentage declined slightly to 25.7% from 26.1%, attributed to competitive pressures and LIFO inventory impacts. Operating income margin improved to 10.0% from 7.6%.
• Liquidity: Cash provided by operations increased to $12.6 million, up from $7.4 million, largely due to the timing of liability payments and the absence of the prior year's litigation payout.

Guidance, Outlook, Risks, and Unusual Items

• Internal Control Weaknesses: Management and auditors (Deloitte & Touche) issued an adverse opinion on the effectiveness of internal controls over financial reporting. Material weaknesses were identified regarding the support for account balances (allowance for uncollectible notes, deferred taxes, container deposits) and the application of GAAP for depreciation lives. Remediation is underway.
• ERP Implementation: The company is implementing an Enterprise Resource Planning (ERP) system. Capital expenditures for Fiscal 2005 included $3.1 million for this project. Fiscal 2006 expenses are expected to include approximately $1.7 million in additional IT and professional service costs.
• Litigation Resolution: A $3.0 million settlement paid in Fiscal 2004 regarding a personal injury lawsuit (Chavarria et al.) was resolved. In June 2005, the company settled indemnification claims against the former principals of the acquired Universal Chemicals, recovering 75,358 shares of common stock and eliminating a $500,000 future non-compete payment obligation.
• Risk Factors: Key risks include cyclical commodity chemical prices, potential flooding of Mississippi River terminals (mitigated by the Red Rock facility), and reliance on a limited number of suppliers. No single customer represents more than 5% of sales.
• Outlook: Management expects to fund working capital and capital investment needs with internally generated funds. No significant financing activities are anticipated.

Investor Verification Checklist

• Internal Controls: Verify the progress of remediation efforts for the material weaknesses identified in the internal control audit.
• ERP Costs: Monitor actual vs. projected costs for the ERP implementation in Fiscal 2006 to ensure they do not exceed the estimated $1.7 million in incremental expenses.
• Commodity Pricing: Assess the impact of caustic soda price volatility on the Industrial segment's margins, as the company maintains stable dollar margins which compresses percentage margins during price increases.
• Investment Portfolio: Review the status of the $15.6 million in investments classified as non-current due to temporary impairment to ensure they recover to fair value as intended.
• Customer Concentration: Confirm that the top five customers (representing ~11.5% of sales) remain stable, as their loss could materially affect operations.